The GO/KEGG pathway enrichment analysis of 83 potential therapeutic targets showed that AB–DA anti-osteoporosis mainly involved the MAPK signaling pathway, osteoclast differentiation, and the PI3K-Akt signaling pathway. Here, AKT1 is linked to osteoporosis.